Longer duration of obesity is associated with a reduction in urinary angiotensinogen in prepubertal children

被引:0
作者
Manuela Morato
Liane Correia-Costa
Teresa Sousa
Dina Cosme
Franz Schaefer
José Carlos Areias
António Guerra
Alberto Caldas Afonso
Henrique Barros
Ana Azevedo
António Albino-Teixeira
机构
[1] Faculty of Medicine of University of Porto,Department of Pharmacology and Therapeutics
[2] Faculty of Pharmacy of the University of Porto,Department of Drug Sciences, Laboratory of Pharmacology
[3] University of Porto,MedInUP
[4] Faculty of Pharmacy of University of Porto, Center for Drug Discovery and Innovative Medicines
[5] University of Porto,Laboratory of Pharmacology, Department of Drug Sciences
[6] Centro Hospitalar São João,EPIUnit
[7] Faculty of Medicine of University of Porto, Institute of Public Health
[8] University of Heidelberg,Division of Pediatric Nephrology, Integrated Pediatric Hospital
[9] Centro Hospitalar São João,Department of Pediatrics
[10] Centro Hospitalar São João,Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine
[11] University of Porto,Division of Pediatric Cardiology, Integrated Pediatric Hospital
[12] Faculty of Medicine of University of Porto,Division of Pediatric Nutrition, Integrated Pediatric Hospital
来源
Pediatric Nephrology | 2017年 / 32卷
关键词
Angiotensinogen; Obesity; Overweight; Body mass index; Children; Hydrogen peroxide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1411 / 1422
页数:11
相关论文
共 564 条
[1]  
Ng M(2014)Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 384 766-781
[2]  
Fleming T(2010)Obesity-related renal injury in childhood Horm Res Paediatr 73 303-311
[3]  
Robinson M(2006)Vascular risks and management of obesity in children and adolescents Vasc Health Risk Manag 2 171-187
[4]  
Thomson B(1996)Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study Metabolism 45 235-240
[5]  
Graetz N(2012)The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms Crit Rev Biochem Mol Biol 47 379-390
[6]  
Margono C(2008)Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans J Hypertens 26 831-843
[7]  
Mullany EC(2012)The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome Curr Hypertens Rep 14 160-169
[8]  
Biryukov S(2013)The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity J Nutr Biochem 24 2003-2015
[9]  
Abbafati C(2010)Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy Am J Hypertens 23 425-431
[10]  
Abera SF(1997)ACE, angiotensinogen and obesity: a potential pathway leading to hypertension J Hum Hypertens 11 107-111